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THE effect of cetirizine on plasma membrane fluidity and
heterogeneity of human eosinophils, neutrophils, plate-
lets and lymphocytes was investigated using a fluores-
cence technique. Membrane fluidity and heterogeneity
were studied by measuring the steady-state fluorescence
anisotropy and fluorescence decay of 1-(4-
trimethylammonium-phenyl)-6-phenyl-1, 3, 5-hexatriene
(TMA-DPH) incorporated in the membrane. The results
demonstrate that cetirizine (1 tg/ml) induced a signifi-
cant increase in the Hpid order in the exterior part ofthe
membrane and a decrease in membrane heterogeneity in
eosinophils, neutrophils and platelets. Moreover,
cetirizine blocked the PAF induced changes in membrane
fluidity in these cells. Cetirizine did not influence signifi-
cantly the plasma membrane of lymphocytes. These data
may partially explain the effect ofcetirizine on inflamma-
tory cell activities.
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Introduction
Cetirizine, a piperazine derivative and carboxy-
lated metabolite of hydroxyzine in humans, is a long-
acting non-sedating, histamine Hi-receptor antago-
nist. Apart from its potency in inhibiting
histamine-induced reactions, several antiallergic ef-
fects of cetirizine are not explained by antagonism of
the Hi-receptor. Recent investigations have demon-
strated for instance that cetirizine has a modulating
effect on different cells possibly involved in the
allergic inflammatory phenomenon. Among these are
eosinophils (Eos), neutrophils (PMN) and platelets
(Plt). Cetirizine inhibits Eos chemotaxis,
’-4 accumu-
lation,5- adherence and activation.9,m Moreover, it
inhibits an antigen-induced PMN accumulation in
atopic skin.9,m In addition, oxygen free radical gen-
eration following IgE dependent activation of Pit and
antigen-induced platelet-dependent leukopenia are
inhibited by cetirizine.1," All of these cellular activi-
ties are the result of complex events mediated by
plasma membrane.
It has long been recognized that cell membranes
have fundamental physiological tasks, in addition to
their action as selective boundaries. In fact, most of
the cellular biochemical and biophysical events oc-
cur in the membrane, where strict structural and
dynamic features provide the control mechanisms.3
Membrane fluidity has an important role in modu-
lating cell functions, affecting the conformation of
membrane proteins and the exposure and diffusion
of membrane components. Fluidity is a complex
physico-chemical feature that depends upon mobil-
ity and order of membrane constituents. 3,14 This
study was performed to discern the effect of
cetirizine on membrane fluidity and heterogeneity
of human Eos, PMN, Pit and lymphocyte using
a fluorescence technique. As a fluorescent
probe we employed 1-(4-trimethylammonium-
phenyl)-6-phenyl-1, 3, 5-hexatriene (TMA-DPH).
Material and Methods
Blood samples were obtained from healthy do-
nors. All subjects were without signs of acute infec-
tion and had not suffered from infection in the
previous 3 weeks. None of the subjects enrolled in
the study was undergoing anti-inflammatory or anti-
histamine therapy.
For the preparation of eosinophils, blood samples
were obtained from ten subjects having a docu-
mented seasonal allergic rhinitis and a positive skin
test for only grass pollen. Samples were obtained
before the grass pollen season. Patients were not
under specific hyposensitization and had not taken
any medications in the previous 2 months.
Preparation ofPMN.. PMN were isolated from freshly
drawn blood using a Mono-Poly Resolving Medium
(ICN Biomedicals, Milan, Italy) as described previ-
ously.5 A sample of 3.5 ml of heparinized blood
was layered onto 3 ml of Mono-Poly Resolving Me-
dium and centrifuged at 300 xg for 45 min at room
temperature. The PMN band was transferred to a
sterile tube. Cells were washed and resuspended
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in Krebs-Ringer phosphate solution (KRP) supple-
mented with 5 mM glucose. The total PMN count was
obtained using a Sysmex E-2500 whole blood ana-
lyser.
Preparation ofeosinophils: Eosinophils were isolated
according to Koenderman et al. 16 Polymorpho-
nuclear leukocytes were isolated as described previ-
ously15 and cells were suspended at a final concen-
tration of 75 x 106 cells/ml. Cells were incubated with
fMLP (final concentration 10 nM) for 10 min. One ml
of the cell suspension was layered on a discontinu-
ous double-layered Percoll (Pharmacia, Uppsala,
Sweden) gradient of densities 1.082 and 1.100 g/ml
and centrifuged for 15 min at 1000 xg. Eos were
collected from the interface between the two Percoll
layers and washed with KRP and glucose. The differ-
ential cell count, determined from May-Gruenwald/
Giemsa stained smear, indicated that isolates were
90% Eos.
Preparation of platelets: Ten ml of freshly drawn
acid-citrate-dextrose anticoagulated blood was cen-
trifuged at 120g for 15 min at 37C to prepare
platelet rich plasma. Pit were isolated and washed
according to Kubina et al.7 Pit were finally resus-
pended in Tyrode’s buffer (137 mM NaCl, 2 mM KCl,
12mM NaHCO3, 0.3 mM NaHiPO4, 1 mM MgCI.,
5 mM glucose) with 0.1% bovine serum albumin and
Apyrase (Sigma Chemical Co., St Louis, MO). The Pit
suspension was adjusted to a concentration of 4 x 108
Plt/ml.
Phase-contrast microscopy (Diaplan, Leica, Milan,
Italy) showed that, under the conditions used, con-
trol and TMA-DPH Pit remained discoid and func-
tional, being sensitive to thrombin (1 U/ml). TM
66, equipped with a Perkin-Elmer 7300 Personal
Computer for data acquisition and elaboration as
described previously,
i The computer program calcu-
lated fluorescence anisotropy by using the expres-
sion (I,-I+/- x g)/(I, + [2I+/- x g]) where g is an instrumen-
tal correction factor, /, and I+/- are respectively the
emission intensities with polarizers parallel and per-
pendicular to the direction of the polarized exciting
light.
Fluorescence lifetime measurements were per-
formed as described previously
2 with a multi-
frequency phase fluorometer. The instrument was
equipped with an ADC interface (ISS Inc., Cham-
paign, IL, USA) for data collection and analysis; the
excitation wavelength was set at 325 nm (ultraviolet
line of a helium/cadmium laser, Liconix Model 4240
NB). The range of modulation frequencies used for
TMA-DPH was 17-130 MHz. Data were accumulated
at each modulation frequency until the standard
deviation of the phase and modulation values were
below 0.1 and 0.002, respectively. The fluorescence
was measured through a long-pass filter (type RG 370
from Janos Tecnology, Townshend, VT, USA) which
showed negligible luminescence. The experimental
data were analysed by a model that assumes a con-
tinuous distribution of lifetime values characterized
by Lorentzian shape centred at a time C and having
a width Wo22 For this analysis the program minimizes
the reduced chi-squared defined by an equation
reported by Fiorini et al." The temperature of the
samples was maintained at 37C with an external
bath circulator.
Analysis of the results: The data were compared by
Student’s t-test. The level of significance was taken at
p< 0.05.
Preparation of lymphocytes: Lymphocytes were pre-
pared from freshly drawn blood using Lymphocyte
Separation Medium LymphoSep (ICN Biomedicals)
as described previously. 19 Two ml heparinized blood
diluted 1:1 with KRP solution was layered over 4 ml
of LymphoSep and centrifuged at 400 xg for 20 min
at room temperature. The lymphocytes band was
washed and resuspended in KRP solution.
Cell count was determined using a Sysmex E-2500
whole blood analyser. Cells were immediately used
for fluorescence measurements. Labelling with TMA-
DPH was carried out in the dark. TMA-DPH was
added to the cell suspension to give a final concen-
tration of 1 l.tM. Fluorescence measurements were
performed before and after addition of cetirizine
(1 l.tg/ml). PAF was later added to the samples at a
final concentration of 10-7 M.
Fluorescence studies: Steady-state fluorescence
anisotropy (rs) measurements were performed at
37C with a Perkin-Elmer Spectrofluorometer MPF-
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Results
The background phospholipid fluorescence of
cells (Eos, PMN, Pit or lymphocytes) was checked
prior to each measurement and was less than 0.5% of
the fluorescence when TMA-DPH was added. The
fluorescence intensity of cetirizine in the suspension
solution at the used concentrations was negligible
and did not increase upon the addition ofTMA-DPH
or PAF.
In the control cell samples (without cetirizine) a
stable rs value was maintained for the following
30 min. The results of r values in Eos, PMN and Pit
before and after addition of cetirizine, 1 l.tg/ml, and
PAF are shown in Figs 1-3. When cetirizine was
added at a concentration of 0.1 l.tg/ml no significant
changes of r values were observed (data not shown).
The effect of PAF on these cells was not blocked in
the presence of cetirizine. However, at a concentra-
tion of 1 t.tg/ml, cetirizine induced a significant and
stable increase in r value. The subsequent additionCetirizine and inflammatory cell membranes
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FIG. I. Steady-state fluorescence anisotropy (rs) of TMA-DPH at 37C in
Eos plasma membranes before) and after ([i]) addition of cetirizine and
PAF (), Values are expressed as the mean + 2S.D. of ten samples. The
addition of cetirizine induced a significant increase in rs value (p < 0.0001).
0.3500"
0.3300"
0.3100
4 7 9 10 11 12 13 14 15 16 17 18 19 20 21
Time (min)
FIG. 4. Steady-state fluorescence anisotropy (q) of TMA-DPH at 37C in
lymphocyte plasma membranes before ) and after ([i]) addition of
cetirizine and PAF (). Values are expressed as the mean + 2S.D. of ten
samples. The addition of PAF induced a significant increase in r, value
(p < 0.0001).
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FIG. 2. Steady-state fluorescence anisotropy (r,) of TMA-DPH at 37C in
PMN plasma membranes before) and after (11]) addition of cetirizine and
PAF (). Values are expressed as the mean + 2S.D. of ten samples. The
addition of cetirizine induced a significant increase in r, value (p < 0.0001).
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FIG. 3. Steady-state fluorescence anisotropy (rs) of TMA-DPH at 37C in
Pit plasma membranes before) and after ([) addition of cetirizine and
PAF (). Values are expressed as the mean + 2S.D. of ten samples. The
addition of cetirizine induced a significant increase in value (p < 0.0001).
of PAF to cells did not induce significant changes in
membrane fluidity (p > 0.5). The addition of
cetirizine to lymphocytes neither induced significant
changes in rs values, nor reduced the effect of PAF
addition (Fig. 4).
Figures 5-7 show the results of the lifetime distri-
bution of analysis of TMA-DPH decay in cell mem-
branes in the absence (A) or presence (B) of
cetirizine (1 ILtg/ml). Eos in the absence of cetirizine
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FIG. 5. (A) TMA-DPH lifetime distribution in Eos plasma membrane.
(B) TMA-DPH lifetime distribution in Eos plasma membrane after addition
of cetirizine (1 pg/ml).
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FIG. 6. (A) TMA-DPH lifetime distribution in PMN plasma membrane.
(B) TMA-DPH lifetime distribution in PMN plasma membrane after addition
of cetirizine (1 lg/ml).
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FIG. 7. (A) TMA-DPH lifetime distribution in Pit plasma membrane.
(B) TMA-DPH lifetime distribution in Pit plasma membrane after addition of
cetirizine (1 lg/ml).
(Fig. 5A) showed a two-component distribution; a
long component with an average lifetime value (CL)
of 5.919 ns and fractional intensity (f,) of 0.734, and
a short component with an average lifetime value
(Cs) of 0.512 ns and fractional intensity (fs) of 0.266.
The distribution width of the long component (Wt)
was 0.307 ns and 0.178 for the short component
(Ws). After the addition of cetirizine to Eos a signifi-
cant reduction in W,. was observed (value after addi-
tion of cetirizine O.187 ns), whereas C,., f,, Cs, Ws and
fs did not change significantly (Fig. 5B).
PMN in the absence of cetirizine showed a two
component distribution, the long component was
characterized by a C,. of 6.879 ns, Wt of 0.208, and f,.
of 0.696, and the short component Cs of 0.743 ns, Ws
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of 0.050 and fs of 0.304 (Fig. 6A). After the addition
of cetirizine a significant reduction in W,. value was,
observed (0.167). Ct, f,, Cs, Ws and fs were not
significantly changed after the addition of cetirizine
(Fig. 6B).
Pit in the absence of cetirizine showed a long
component with a Ct of 5.402 ns, WL of 0.254 and fL
of 0.790, and a short component with a Cs of
1.210 ns, Ws of 0.050 and fs of 0.210 (Fig. 7A). The
addition of cetirizine reduced the W,. significantly
(0.192 vs. 0.254). However, Ct, fst, Cs, Ws and fs were
not sig,nificantly changed (Fig. 7B).
Lymphocytes in the absence of cetirizine showed
a long component with a C, of 5.418 ns, W,. of 0.201
and f,. of 0.831, and a short component with a Cs ofCetirizine and inflammatory cell membranes
0.522 ns, Ws of 0.050 an fs of 0.169. The addition of
cetirizine did not induce significant changes in these
parameters.
Discussion
The plasma membrane, located at the interface
between the external environment and the cell meta-
bolic machinery, is the site of the regulatory events
which control functional activities and cellular pro-
cesses. Communication and stimulus-response
coupling across and along the cell membrane pro-
vide a basis for functions such as motility, adhesion,
aggregation and immune response.
24
To mediate such functions, lipids act as barriers,
solvents, anchors, activators and conformational sta-
bilizers for proteins that carry out specific functions. 25
The membrane functional diversity is reflected in the
wide variety of lipids and proteins that compose
different membranes.
The fluid mosaic model describes the cell mem-
brane as a fluid two-dimensional lipid bilayer matrix
with its associated proteins that allows for lateral
diffusion of both lipids and proteins in the plane of
the membrane. 26 Specific lipid-lipid and lipid-pro-
tein interactions result in a precisely controlled yet
highly dynamic architecture of the membrane com-
ponents, as well as in its selective modulation by the
cell and the environment.27 Different modes of or-
ganization of the compositionally and functionally
differentiated domains would correspond to differ-
ent functional states of the membrane, is A key issue
in the fluid mosaic model is membrane fluidity which
reflects the physical properties of lipids and has been
found to correlate with the activity of several mem-
branes. 29 A variety of spectroscopic techniques have
been employed for the investigation of the structure
and dynamic properties of synthetic and natural
membranes. In particular, fluorescence techniques
have been used to investigate membrane fluidity by
means of extrinsic probes embedded in the mem-
brane. 1,6-diphenyl-l,3,5-hexatriene (DPH) and its
derivatives are perhaps the most commonly used
probes to investigate the physical structural proper-
ties of membranes at the molecular level.3-32
TMA-DPH is a fluorescent hydrophobic probe, intro-
duced in 1981 by Prendergast et aL In addition to
its favourable photophysical characteristics (similar
to those of DPH) in membranes, it remains anchored
by its charged trimethylammonium group at the level
of the lipid-water interface region for at least 30 min
allowing measurements in intact cells.1
TMA-DPH rs values reflect the packing of mem-
brane lipid fatty acid chains and can be related to
the order parameter, S, if certain precautions are
taken.4,5 Lipid fluidity may be defined as the
reciprocal of the lipid structural order parameter
S34 a_nd thus an increase of TMA-DPH rs value
corresponds to a decrease in membrane fluidity.
In this study it was observed that cetirizine at a
concentration of 1 lttg/ml increased significantly
TMA-DPH rs values in Eos, PMN and Pit. This
indicates that cetirizine (1 lttg/ml) induces a decrease
in fluidity which reflects an increase in lipid order-
ing in the exterior part of the plasma membrane of
cells. A lower concentration of cetirizine, 0.1 t.tg/ml,
did not induce significant changes in r, values (data
not shown). In lymphocytes cetirizine did not
influence TMA-DPH r, values and this confirms
previous data demonstrating that this drug does not
affect lymphocyte function in vitro. To discern if
these changes in membrane fluidity induced by
cetirizine could influence the previously observed
effect of PAF on these cells,18,7,s PAF 10-7 M was
added to these samples. In Eos, PMN and Pit the
effect of PAF was abolished by cetirizine.
TMA-DPH fluorescence decay depends on the
dielectric constant of the medium in which the probe
is embedded.9 Therefore the width of the lifetime
distribution can be related to the different physico-
chemical properties of the environment surrounding
the probe. The distribution analysis, although based
on phenomenological grounds, offers a good
description of membrane heterogeneity.4,41 In our
distribution analysis it was necessary to include a
second component at shorter lifetime with a low
fractional intensity. The origin of this component is
still debated; for DPH this component has been
referred to as a photochemical derivative of the
probe4 or alternatively, it can represent a fraction of
the probe localized in a very polar environment.42 In
this study the short component was not influenced
by the addition of cetirizine. The data for TMA-DPH
lifetime distribution show that cetirizine induced a
decrease in the long component width in Eos, PMN
and Pit. No effect was observed on lymphocyte
membrane. These results indicate that cetirizine in-
duces a decrease in membrane heterogeneity of
these cells at the lipid-water interface.
Various authors have indicated a direct effect of
cetirizine on Eos,2-5 PMN9,m and Plt. This study
demonstrates that cetirizine can influence membrane
fluidity, which plays an important role in modulating
cell functions, is It is thus plausible that the observed
changes in membrane fluidity and heterogeneity in-
duced by cetirizine can alter membrane associated
activities of these cells. The fact that Eos, PMN and
Pit treated with cetirizine blocked the effect of PAF
on membrane fluidity of these cells may be on the
basis of the previous observations of a reduction of
membrane receptor mediated cell activities triggered
by PAF or other agents such as N-formyl peptide
or IgE. 5,7,9,11
This study demonstrates that cetirizine, at a con-
centration of 1 g/ml, can influence plasma mem-
brane fluidity of Eos, PMN and Pit. Cetirizine de-
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creases membrane fluidity and heterogeneity at the
lipid-water interface. The observed changes can be
attributed to a possible interaction of cetirizine with
cell membrane components (lipids of proteins) or the
cell cytoskeleton that can influence the membrane.
The possibility of an interaction of cetirizine with a
specific membrane receptor (W. Konig, personal
communication) or with nonspecific receptors can-
not be excluded. These findings may partially ex-
plain the effect of cetirizine on cell functions. Further
studies are needed to explain the mechanisms of
cetirizine-cell interaction.
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